LLY Research and Charts

LLY - Eli Lilly and Co (Healthcare: Drug Manufacturers - General)

Projected Earnings Date: 2025-11-05 (Delayed quote data 2025-09-16)

Last 764.37	Change ⇑ +15.75 (+2.10%)	Volume 3,875,664
	Open 746.49	High 770.38	Low 744.54

8EMA (Daily) 750.68	40EMA (Daily) 738.68	50EMA (Daily) 741.45	STO (Daily) 88.508	MACD Hist (Daily) 8.286
8EMA (Weekly) 742.157	40EMA (Weekly) 773.07	50EMA (Weekly) 773.99	STO (Weekly) 56.848	MACD Hist (Weekly) 4.209


Company Profile
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.